Search results for #ASPCExpertsCourse
How to incorporate CV #genetics into practice? @amitvkhera provides a framework for complementary nature of mono and polygenic variants. Reminds that DNA is not destiny @ASPCardio #ASPCExpertsCourse
@DrNathanWong always gives an insightful talk on risk assessment, taking us through an authoritative history of the topic. He was part of first NIH study on CAC and much of the seminal literature in the area @ASPCardio #ASPCExpertsCourse
Did you know... that in 1961 the work “risk factors” was first used? Dr. Kannel said it #FraminghamStudy @ASPCardio #ASPCCongress2019 #AspcExpertscourse @dramitkhera @SamRRazaMD @SethJBaumMD @SethShayMartin @DrMichaelShapir @RonBlankstein @ErinMichos @DrRyanPDaly @thebyrdlab
#ORBITA trial was negative study and so important because double blinded sham PCI trial. Lots of criticism but great trial showing again OMT and PCI not really different for anginal relief or exercise time @ASPCardio #ASPCCongress2019 #Aspcexpertscourse @dramitkhera @iamritu
So much data not supporting PCI over OMT in IHD management yet we somehow don’t believe in medical therapy. #ASPCCongress2019 @ASPCardio #aspcexpertscourse @dramitkhera @SamRRazaMD @SethJBaumMD @SethShayMartin @RonBlankstein
Linear relationship between number of vessels diseased but nothing about prox LAD disease that makes patients at higher risk and no differences in PCI vs OMT Dr. Boden @ASPCardio #ASPCCongress2019 #aspcExpertscourse
#CAC is useful in those with intermediate risk and has risk enhancers to help guide therapy. @dramitkhera @ASPCardio #ASPCCongress2019 #ASPCExpertsCourse @SethJBaumMD @SethShayMartin @ErinMichos @DrMichaelShapir @SamRRazaMD @RonBlankstein
#ASPCCongress2019 #ASPCExpertsCourse @aspc @dramitkhera presenting on integrating imaging and ASCVD Prevention ♥️ stress testing can be falsely reassuring ♥️ CAC more useful ♥️CAC in prevention guidelines ♥️Risk enhancers should be assessed
